- GLP-1 medications produce large weight loss — but a review found they can cause roughly 10% (about 6 kg) loss of lean mass, comparable to a decade or more of aging.
- Two levers protect muscle: adequate protein (about 1.6–2.2 g/kg/day) and resistance training, which can add lean mass even during treatment.
- Good monitoring tracks body composition and strength, not just the number on the scale.
- Used with a protein-and-training plan, the medication becomes a bridge to durable results rather than a cause of muscle loss.
GLP-1 medications like semaglutide and tirzepatide are the most effective weight-loss drugs we have ever had. They are also easy to use badly. The problem is not the medication — it is what happens when a powerful appetite suppressant is handed over without a plan to protect the one tissue you cannot afford to lose: muscle.
What the medication does — and doesn't
These drugs mimic gut hormones that slow stomach emptying, blunt appetite, and improve blood sugar. In the STEP 1 trial, semaglutide produced roughly 15% average body-weight loss over 68 weeks — a genuinely large effect. But weight is a mix of fat and lean tissue, and rapid loss takes both. A 2024 review in Diabetes Care put numbers on it: incretin-based medications can cause about a 10% loss of lean mass — roughly 6 kilograms — an amount the authors compared to a decade or more of normal aging, and they explicitly recommended resistance training to counter it.
That is the whole case for doing GLP-1 the right way. The medication handles appetite and fat. Protecting muscle is your job — and it is very doable.
Lever one: protein, made deliberate
When appetite drops sharply, protein does not happen by accident. Make it the priority at every meal:
- Aim for about 1.6 to 2.2 grams of protein per kilogram of body weight per day, toward the higher end while actively losing weight.
- Spread it across three to four meals (30–45 grams each) to keep the muscle-maintenance signal on through the day.
- Eat protein first, before fullness arrives.
- Use liquid protein — shakes, Greek yogurt — on days nausea or early satiety makes solid food hard.
Lever two: resistance training
This is the non-negotiable partner to the medication. The same Diabetes Care review noted that supervised resistance training can add meaningful lean mass and strength — enough to offset much of the muscle a GLP-1 drug would otherwise cost. Practically:
- Lift at least twice a week — the evidence-backed minimum to preserve, and often build, muscle during weight loss.
- Train the whole body — push, pull, squat or hinge, and carry.
- Progress gradually — a little more weight, a rep, or a set over time.
- Recover well — sleep and rest days are when muscle is actually maintained.
Lever three: monitor the right things
"Is the scale moving?" is not enough oversight. A good program tracks whether you are losing the right weight:
- Body composition — lean mass and fat mass, via DXA or bioimpedance, not just total weight.
- Strength — are your benchmarks holding or improving?
- Protein adherence — are you actually hitting the target?
- Nutrient status and side effects — because appetite suppression can quietly compromise nutrition, and side effects need watching.
The endgame
Here is why this matters beyond the gym: preserving muscle also protects your results. When people stop a GLP-1 medication without new habits, most of the weight tends to return — the STEP 1 extension showed substantial regain after withdrawal. Muscle, protein habits, and training are what make the loss durable. Approached this way, the medication is not a crutch you are stuck on. It is a bridge that carries you to a stronger, more resilient metabolism — and then you walk off it on your own two (well-muscled) legs.
This article is educational and not medical advice. Decisions about starting, dosing, or stopping GLP-1 medications belong in a visit with a qualified prescriber.
In practice: why this matters
GLP-1 medications are being prescribed to millions, often without a structured plan to protect muscle. If that continues at scale, we risk a population that is lighter but weaker — trading obesity for sarcopenia. Pairing these powerful drugs with the simple, well-evidenced habits that preserve muscle is one of the most important public-health details of the GLP-1 era.
Frequently asked questions
Do GLP-1 medications really cause muscle loss?
They cause loss of lean mass as part of rapid weight loss — a 2024 review estimated roughly 10% or about 6 kg, similar to a decade or more of aging. That's not a reason to avoid them; it's a reason to pair them with resistance training and adequate protein, which can preserve or even build muscle during treatment.
What should my prescriber be monitoring beyond weight?
Body composition (ideally lean mass via DXA or BIA), strength benchmarks, whether you're actually hitting protein targets, and nutrient status during appetite suppression — plus standard safety monitoring for side effects. 'The number is going down' is not enough oversight.
References
- Wilding JPH, Batterham RL, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021;384:989–1002. doi:10.1056/NEJMoa2032183
- Locatelli JC, Costa JG, et al. Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition? Diabetes Care. 2024;47(10):1718–1730. doi:10.2337/dci23-0100
- Wilding JPH, Batterham RL, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide (STEP 1 trial extension). Diabetes, Obesity and Metabolism. 2022;24(8):1553–1564. doi:10.1111/dom.14725
Peer-reviewed sources located via PubMed and cited for education. Citations reflect published research at time of writing.
This article is for educational purposes and is not a substitute for individualized medical care. Talk with a qualified clinician about your specific situation.
